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The article by Reinartz et al. raises interesting and im-
portant issues regarding PET-CT by comparing PET and
separately acquired CT. The major conclusions of the 
authors are twofold. First, they conclude that only a rela-
tively small number of patients would potentially benefit
from PET-CT, given that the classification of a lesion re-
mains equivocal in only a small number of patients when
PET and CT are carefully evaluated side-by-side. Sec-
ond, they report that in almost half their patients, proper
interpretation of a PET scan requires the availability of a
recent CT scan for comparison. This fraction increases to
two-thirds if only those PET scans that show disease are
taken into account. This article is eye-opening with re-
gard not only to the actual findings but also to the bias
induced by the vantage point from which the data are
considered. PET-CT is a combined modality system. The
authors view PET-CT from a nuclear medicine perspec-
tive, but it may also be illustrative to consider PET-CT
from a radiologist’s or, better still, a future integrated
modality imager’s perspective.
From the vantage point of nuclear medicine, the 
really dramatic finding in this study is that almost half of
the PET scans could not be properly interpreted alone,
with CT also being required in order to properly classify
the findings. When only lesion-positive PET scans were
taken into account, this figure rose to 67%. It would be
interesting to ask what fraction of PET experts carefully
analysed CT scans together with PET scans prior to the
pre-PET-CT era. I freely admit that our team did not do
so consistently before we started to operate our PET-CT
scanner in early 2001. The data of Reinartz et al. amply
demonstrate that molecular and anatomical imaging
modalities are complementary, and that an intellectual
synthesis of the findings of the two modalities is ex-
tremely relevant. Interpreting a PET scan without a cor-
responding CT scan is apparently close to unacceptable
medical practice.
From a nuclear medicine point of view, there are thus
significant advantages of PET-CT: 
1. If it is indeed the case that half of all PET scans and
two-thirds of positive PET scans need CT for proper
interpretation, it would certainly be very convenient
to acquire CT together with PET in a “one-stop shop”
procedure. With this approach, the necessary data are
always available, and they are available in a form
where electronic fusion of PET and CT images poses
no major problems.
2. In PET-CT, attenuation correction resulting in consis-
tent lesion activity and allowing PET standardised 
uptake value measurements comes virtually free. The
higher cost of the systems is offset by the higher pa-
tient throughput.
3. Fast transmission correction has the added advantage
that fluorodeoxyglucose (FDG) and other 18F-based
radiopharmaceuticals can be used more efficiently,
thereby decreasing the per-dose cost of FDG.
Thus, from a nuclear medicine perspective, PET-CT is
advantageous because it is practical, even though most
lesions can be classified when interpreting PET and CT
side-by-side. CT, whether fused or separate, helps to
specify lesions: experience of the potential value of radi-
ology in this respect was first gained 30 years ago when
comparing bone scans and X-rays of osseous and joint
lesions. But, as then, the radiological part of the exami-
nation offers much more than just a gain in specificity.
From a radiologist’s perspective, things look differ-
ent, and the article by Reinartz et al. does not discuss
this. As clinicians become accustomed to PET-CT—and
they will quickly learn that PET without CT is less than
half as good—they will no longer order a CT scan and
then a separate PET scan, but will rather refer patients
directly to PET-CT instead. Then the issue will be opti-
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future and want to keep PET-CT for themselves. Despite
this turf war, it is clear that competence in both fields is
required, and few directors of nuclear medicine or radi-
ology services are fortunate enough to be doubly board
certified. The “turf problem” will become even more rel-
evant with the introduction of more potent SPECT-CT
systems. However, while turf battles are currently being
fought over power or money, they will be irrelevant in
the future, because competence will prevail. This compe-
tence is to be acquired, as always, through learning. Nu-
clear physicians in training readily learn cross-sectional
imaging as they read PET-CT scans, and many young ra-
diologists are now again opting to obtaining double
board certification. They understand that molecular im-
aging is important and in essence resides with nuclear
medicine, because even the best method in this respect 
to be “owned” by the radiologists, namely magnetic 
resonance imaging, has major limitations with regard to
molecular imaging.
So what is to be done in this situation? I believe there
is an urgent need for the imaging community to come 
together to define ways in which board-certified compe-
tence in dual-modality imaging can be obtained. Ulti-
mately the most reasonable approach will be the forma-
tion of imaging departments which resemble neither 
radiology nor nuclear medicine departments but which
offer board certification and subspecialisation titles in
the various, relatively disparate fields of imaging and
image-guided therapy. PET-CT may well be the imaging
technology which allows both parties to stop feuding, to
take a “fresh look at the battlefield” and to redraw
“fences” in ways which make sense rather than being
based on power and monetary issues only. I believe that
we owe this to our young colleagues, who work hard in
learning the necessary prerequisites for success in medi-
cal imaging. We should think less of defending our
“turf” and more of defining reasonable prerequisites for
board certification so that our residents will become re-
spected partners of our clinical colleagues. Both nuclear
medicine and radiology have developed so fast that there
is still plenty of ground to cover. Only through unity will
we be able to maintain the highest training standards,
and this is the key to preventing clinicians from starting
to perform these examinations by themselves. In oncolo-
gy this may not be a major issue, but if a new generation
of PET-CT or SPECT-CT scanners were able to provide
a “one-stop shop” examination for the heart, this could
become critical. Let us prepare now! A quote from
Mikhail Gorbachev may be relevant in this context:
“those who come late will be punished by life”.
1463
European Journal of Nuclear Medicine and Molecular Imaging Vol. 31, No. 11, November 2004
misation not only of PET during PET-CT, but also of the
CT component, so that all information relevant to a 
given diagnostic problem is obtained, thereby providing
a true one-stop shop examination. How to perform the
CT portion of the examination to provide an adequate
one-stop shop in various diagnostic settings is a key
question that will require substantial clinical research
work over the coming years. Some examinations may be
adequate with unenhanced CT only, while other diagnos-
tic situations will require the CT capabilities to their
maximum. Thus, the trend in the industry to provide
PET-CT scanners with high- to medium-end CT scanners
is understandable.
What are the additional items of information that a
CT scan offers over and above that provided by a PET
scan? There is much relevant diagnostic information
which can be gained only with CT. In addition to the pre-
cise lesion localisation afforded by CT in PET-CT, CT
but not PET is able to visualise disseminated small pul-
monary metastases, pleural effusions and other fluid 
collections such as ascites or cystic structures, alterations
in lung and liver parenchyma, and calcifications, thereby
frequently offering additional relevant diagnostic infor-
mation. With contrast enhancement, the relation of le-
sions to vascular structures can be defined with CT; such
information may be of crucial relevance to the surgeon
when operating on patients with central bronchial carci-
noma or tumours affecting the upper abdomen and
specifically the liver. All this additional information, 
accessible using simple or more advanced CT imaging
protocols, may play a critical role in making the correct
diagnosis or providing accurate staging information. CT
thus contributes sensitivity in addition to specificity.
Reinartz et al. in essence ignore the CT information, as
they are using CT only to improve the classification of
the PET lesions. They do not ask the question, “What
can CT itself add to PET-CT?”
PET-CT has thus far been primarily in the hands of
nuclear physicians. Various solutions have been pro-
posed to the question of how to gain the radiological
competence needed to properly interpret the CT data.
Frequently, nuclear physicians interpret the PET data and
radiologists the CT data, and then discuss the case. This
may be a reasonable start, particularly when substantial
cross-training occurs, but it is certainly not cost effec-
tive. It seems unfortunate that PET-CT is in danger of
becoming the subject of a “turf war”: radiologists are
well aware of the power of PET and therefore want to
“get a piece of the action”, while nuclear physicians 
realise that PET-CT is one or perhaps the avenue to their
